Standardizing process development in ADC manufacturing

“ADC production relies on coordination among multiple internal and external partners responsible for antibody supply, linker–payload synthesis, conjugation, and final drug-product manufacturing.”

On October 23, 2025, Lauren Coyle, Launch Commissioning Editor of Bioconjugation Insights, spoke with Eric Lacoste, Global Head of BioProcessing Engineering at Sanofi, about current approaches to ADC manufacturing and the technological and organizational factors that influence process design and scale-up. This article is based on that interview.

Please enter your email to access content Read now